Profile data is unavailable for this security.
About the company
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
- Revenue in EUR (TTM)2.01bn
- Net income in EUR22.03m
- Incorporated1999
- Employees999.00
- LocationMedios AGHeidestrasse 9BERLIN 10557GermanyDEU
- Phone+49 30 232566800
- Fax+49 30 232566801
- Websitehttps://medios.group/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SIGA Technologies Inc | 145.13m | 62.75m | 409.69m | 46.00 | 6.56 | 2.39 | 6.48 | 2.82 | 1.03 | 1.03 | 2.40 | 2.84 | 0.8069 | 0.7425 | 23.63 | 3,744,558.00 | 34.88 | 27.72 | 39.21 | 33.36 | 76.29 | 86.06 | 43.23 | 44.28 | 7.24 | -- | 0.00 | 37.70 | -0.8561 | 38.99 | -13.01 | -- | 7.85 | -- |
| Medios AG | 2.01bn | 22.03m | 426.46m | 999.00 | 19.19 | 0.7908 | 7.11 | 0.2119 | 0.8714 | 0.8714 | 78.98 | 21.14 | 2.17 | 21.52 | 12.29 | 2,006,511.00 | 2.38 | 2.59 | 3.37 | 3.09 | 9.66 | 6.53 | 1.09 | 0.8621 | 1.31 | 4.76 | 0.2765 | 0.00 | 5.51 | 29.51 | -33.29 | 5.15 | 24.73 | -- |
| Cuorips Inc | 1.96m | -4.22m | 430.97m | 56.00 | -- | 15.56 | -- | 219.59 | -93.30 | -93.30 | 43.60 | 607.39 | 0.0656 | 3.33 | 238.00 | 6,351,607.00 | -14.20 | -- | -14.62 | -- | 76.69 | -- | -216.57 | -- | 36.81 | -- | 0.00 | -- | 658.40 | -- | -1.92 | -- | -- | -- |
| Nxera Pharma Co Ltd | 158.36m | -33.90m | 433.42m | 374.00 | -- | 1.20 | -- | 2.74 | -68.13 | -68.13 | 318.44 | 725.52 | 0.1936 | 1.47 | 4.57 | 76,737,970.00 | -4.14 | -1.71 | -4.63 | -1.85 | 71.17 | 84.07 | -21.41 | -10.93 | 2.55 | -11.73 | 0.4902 | -- | 125.87 | 24.28 | 32.74 | -- | 40.57 | -- |
| Shanghai Fudan Forward S&T Co Ltd | 80.65m | -14.52m | 434.97m | 1.41k | -- | 5.73 | -- | 5.39 | -0.1744 | -0.1744 | 0.9721 | 0.9158 | 0.4268 | 0.8015 | 9.29 | 467,663.00 | -7.83 | -3.33 | -14.36 | -5.82 | 32.05 | 39.99 | -18.35 | -7.67 | 0.4787 | -12.63 | 0.4378 | -- | -5.05 | -14.35 | -509.42 | -- | -18.59 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Janus Henderson Investors UK Ltd.as of 17 Oct 2025 | 1.63m | 6.39% |
| Axxion SA (Luxembourg)as of 01 Jan 2026 | 1.55m | 6.09% |
| SEB Investment Management AB (Denmark)as of 02 Jan 2025 | 1.20m | 4.70% |
| Paladin Asset Management Investmentaktiengesellschaft TGVas of 01 Jan 2026 | 613.33k | 2.41% |
| Discover Capital GmbHas of 31 Oct 2025 | 575.00k | 2.25% |
| Cr�dit Mutuel Asset Management SAas of 30 Oct 2025 | 463.00k | 1.82% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 366.50k | 1.44% |
| HC Capital Advisors GmbHas of 31 Oct 2025 | 346.70k | 1.36% |
| Kreissparkasse Biberachas of 28 Nov 2025 | 315.00k | 1.24% |
| GS&P Kapitalanlagegesellschaft SAas of 30 Jun 2025 | 310.00k | 1.22% |
